| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.065 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |